Nrf2 promotes mutant K-ras/p53-driven pancreatic carcinogenesis.

Authors:
Shin Hamada
Shin Hamada
Tohoku University Graduate School of Medicine
Sendai | Japan
Keiko Taguchi
Keiko Taguchi
Tohoku University Graduate School of Medicine
Sendai | Japan
Atsushi Masamune
Atsushi Masamune
Tohoku University Graduate School of Medicine
Sendai | Japan
Masayuki Yamamoto
Masayuki Yamamoto
Tohoku University Graduate School of Medicine
Sendai | Japan
Tooru Shimosegawa
Tooru Shimosegawa
Tohoku University Graduate School of Medicine
Japan

Carcinogenesis 2017 06;38(6):661-670

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.

The Keap1-Nrf2 system contributes to the maintenance of homeostasis by regulating oxidative stress responses in normal tissues and organs, and is exploited in various cancers for proliferation, survival and acquisition of therapy resistance. Pancreatic cancer remains one of the intractable cancers, despite the improved clinical outcomes of other types of cancer, due to its invasive and refractory nature to therapeutic intervention. The current study aimed to clarify the contribution of Nrf2 to pancreatic carcinogenesis using a pancreas-specific mutant K-ras and p53 (KPC) mouse model. Deletion of Nrf2 in KPC mice (KPCN) decreased the formation of precancerous lesions as well as the development of invasive pancreatic cancer. The pancreatic tumor-derived cancer cell lines from KPCN mouse showed decreased expression of glutathione S-transferases (GST), UDP glucuronosyltransferases (UGT) and ABC transporters. Along with these biochemical changes, cell lines from KPCN mice revealed increased sensitivity to oxidative stress and chemotherapeutic agent. The current study revealed that Nrf2 contributes to pancreatic carcinogenesis in a way distinct from the chemoresistance of lung and esophagus, and that Nrf2 could be a novel therapeutic target of pancreatic cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgx043DOI Listing
June 2017
5 Reads

Publication Analysis

Top Keywords

pancreatic cancer
12
pancreatic carcinogenesis
12
lines kpcn
8
cell lines
8
current study
8
oxidative stress
8
pancreatic
7
nrf2
5
cancer
5
carcinogenesis pancreas-specific
4
changes cell
4
mice revealed
4
pancreas-specific mutant
4
mutant k-ras
4
kpc mouse
4
kpcn mice
4
p53 kpc
4
k-ras p53
4
nrf2 pancreatic
4
mouse model
4

Similar Publications

Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.

Am J Physiol Gastrointest Liver Physiol 2018 01 28;314(1):G65-G74. Epub 2017 Sep 28.

Division of Gastroenterology, Tohoku University Graduate School of Medicine , Sendai , Japan.

The Kelch-like ECH-associated protein 1 (Keap1)-NF-E2-related factor 2 (Nrf2) system has a wide variety of effects in addition to the oxidative stress response, such as growth promotion and chemoresistance of cancer cells. Nrf2 is constitutively activated in most cancer cells. However, the activation of Nrf2 together with oncogenic mutations does not always result in cancer promotion. Read More

View Article
January 2018

UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.

J Pathol 2016 Feb 30;238(3):423-33. Epub 2015 Nov 30.

Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK.

The cellular defence protein Nrf2 is a mediator of oncogenesis in pancreatic ductal adenocarcinoma (PDAC) and other cancers. However, the control of Nrf2 expression and activity in cancer is not fully understood. We previously reported the absence of Keap1, a pivotal regulator of Nrf2, in ∼70% of PDAC cases. Read More

View Article
February 2016

The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.

BMC Cancer 2016 Feb 25;16:155. Epub 2016 Feb 25.

Group Inflammatory Carcinogenesis, Institute for Experimental Cancer Research, Christian-Albrechts-University Kiel, Arnold-Heller-Str. 3, Building 17, 24105, Kiel, Germany.

Background: Nuclear factor E2 related factor-2 (Nrf2) is an oxidative stress inducible transcription factor being essential in regulating cell homeostasis. Thus, acute induction of Nrf2 in epithelial cells exposed to inflammation confers protection from oxidative cell damage and mutagenesis supporting an anti-tumorigenic role for Nrf2. However, pancreatic ductal adenocarcinoma (PDAC) is characterized by persistent Nrf2 activity conferring therapy resistance which points to a pro-tumorigenic role of Nrf2. Read More

View Article
February 2016

Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.

Gastroenterology 2014 Nov 12;147(5):1119-33.e4. Epub 2014 Aug 12.

Stem Cells and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Centre for Stem Cells in Cancer & Ageing, Barts Cancer Institute, Queen Mary University of London, UK. Electronic address:

Background & Aims: Although smoking is a leading risk factor for pancreatic ductal adenocarcinoma (PDAC), little is known about the mechanisms by which smoking promotes initiation or progression of PDAC.

Methods: We studied the effects of nicotine administration on pancreatic cancer development in Kras(+/LSLG12Vgeo);Elas-tTA/tetO-Cre (Ela-KRAS) mice, Kras(+/LSLG12D);Trp53+/LSLR172H;Pdx-1-Cre (KPC) mice (which express constitutively active forms of KRAS), and C57/B6 mice. Mice were given nicotine for up to 86 weeks to produce blood levels comparable with those of intermediate smokers. Read More

View Article
November 2014